Sagimet Biosciences EPS SGMT

Diluted earnings per share by quarter and over the last twelve months, from 2022.

Sagimet Biosciences' earnings per share was −$1.28 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.26.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.26	n/a	−$1.28
Q1 FY26	Mar 31, 2026	−$0.33	n/a	−$1.34
Q4 FY25	Dec 31, 2025	−$0.29	n/a	−$1.57
Q3 FY25	Sep 30, 2025	−$0.40	n/a	−$1.78
Q2 FY25	Jun 30, 2025	−$0.32	n/a	−$1.83
Q1 FY25	Mar 31, 2025	−$0.56	n/a	−$1.76
Q4 FY24	Dec 31, 2024	−$0.50	n/a	−$1.43
Q3 FY24	Sep 30, 2024	−$0.45	n/a	−$1.28
Q2 FY24	Jun 30, 2024	−$0.25	n/a	−$1.18
Q1 FY24	Mar 31, 2024	−$0.23	n/a	−$36.73
Q4 FY23	Dec 31, 2023	−$0.35	n/a	−$72.08
Q3 FY23	Sep 30, 2023	−$0.35	n/a	−$110.79

Companies in Drug Manufacturers - General nearest Sagimet Biosciences' size, closest first, today.

Company	EPS, 12 months	Growth
SGMTSagimet Biosciences	−$1.28
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
IRWDIronwood Pharmaceuticals	$0.77
PBYIPuma Biotechnology	$0.52	−47% a year
ARVNArvinas	$0.16
COLLCollegium Pharmaceutical	$1.24	+19% a year
ABUSArbutus Biopharma	$0.78
AMPHAmphastar Pharmaceuticals	$1.70	−36% a year
OMEROmeros	$1.52
PCRXPacira BioSciences	$0.35
Peer median	$0.85